High versus standard-protein provision and muscle loss in critically ill patients assessed by muscle ultrasound: A prospective ancillary study of a randomised controlled trial
In brief
Higher-protein feeding did not reduce muscle loss in ventilated ICU patients
In this single-center study of 141 mechanically ventilated patients, thigh muscle area fell over time with both standard and higher-protein feeding. The overall loss did not differ significantly between patients receiving 2.0 versus 1.3 grams of protein per kilogram daily, so whether higher protein improves muscle preservation remains unproven.
- Journal
- Clinical nutrition (Edinburgh, Scotland) (Q1)
- Published
- 13 November 2026
- Study design
- Randomized controlled trial
- Evidence level
- Level 1, High (CEBM 1b)
- Authors
- Lara Schepers, Julia L M Bels, Michelle C Paulus, Rob van Gassel, Steven Thiessen, Aude de Watteville, et al.
- PMID
- 43056780
- DOI
- 10.1016/j.clnu.2026.106848
Why clinicians should know about it
- Picked for Critical Care and Intensive Care Medicine (top studies of the week, 22 November 2026): Randomized-trial ancillary study of protein and ICU muscle loss
Abstract
BACKGROUND & AIMS: Rapid skeletal muscle loss, a hallmark of critical illness, has been linked to delayed recovery, prolonged mechanical ventilation, and reduced quality of life. It has been suggested that increased enteral protein delivery may attenuate this muscle loss in critically ill patients. In this study, we examined the effect of high versus standard enteral protein provision on changes in M. rectus femoris cross-sectional area (RFCSA) in mechanically ventilated critically ill patients. METHODS: We performed a prospective, pre-planned, single-centre ancillary study at Maastricht University Medical Centre, embedded within the quadruple-blinded randomised PRECISe trial, which evaluated the effect of standard (1.3 g/kg/day) versus high (2.0 g/kg/day) protein provision on functional recovery in critically ill patients. We included all patients who had baseline (<2 days after randomisation) and at least one follow-up ultrasound measurement of the M. rectus femoris. The primary outcome for this study was the change in RFCSA, measured during ICU stay and up to 30 days after randomisation. RESULTS: A total of 141 participants were included in this analysis (standard-protein group, n=75; high-protein group, n=66). RFCSA decreased over time in both groups, with a mean daily decrease of 0.077 ± 0.065 cm2 (95% CI, -0.10 to -0.05; p < 0.01) and -0.048 ± 0.047 cm2 (95% CI, -0.07 to -0.02; p < 0.01) in patients allocated to the standard- and high-protein groups, respectively. However, the overall change in RFCSA did not differ between groups (mean difference -0.098 cm2; 95% CI -0.24 to 0.044; p = 0.17). CONCLUSIONS: In mechanically ventilated critically ill patients, high enteral protein provision compared with standard enteral protein provision did not attenuate skeletal muscle loss, as assessed by ultrasound-derived RFCSA. TRIAL REGISTRATION: The PRECISe trial was registered at ClinicalTrials.gov (NCT04633421; https://clinicaltrials.gov/ct2/show/NCT04633421) on 23 October 2020.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.